Indian equity indices rebound from two-week low, led by the gains in private lenders. ... The market breadth, however, was tilted in favour of sellers. ... Aurobindo Pharma said U.S. FDA issued Form 483 with 14 observations after ...
Read more: Live: SGX Nifty Suggests Tepid Start; Aurobindo, Bharti Airtel, SpiceJet, Vedanta In Focus